Caspofungin versus anidulafungin in patients with invasive candidiasis: a retrospective study with propensity-score-matched analysis
Background: Echinocandins are recommended as an initial treatment for invasive candidiasis. Although safety and efficacy profiles of both anidulafungin and caspofungin are well established, direct head-to-head comparisons have not been reported before. Objective: Compare efficacy and safety of anidu...
Saved in:
Main Authors: | Reem Hasan Elajez, Dana Bakdach, Sara Al Balushi, Ahmed Zaqout, Rand Alattar, Tasneem Abdallah, Waleed Awouda, Godwin Wilson, Walid Al-Wali, Emad Ibrahim, Hussam Alsoub |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2025-07-01
|
Series: | Therapeutic Advances in Infectious Disease |
Online Access: | https://doi.org/10.1177/20499361251344777 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Pharmacoeconomic analysis of the anidulafungin (EraxisR) in adult patients with invasive candidiasis
by: S. V. Nedogoda, et al.
Published: (2019-10-01) -
A clinical-economic study of caspofungin use in the treatment of invasive candidiasis in intensive care units
by: A. S. Kolbin, et al.
Published: (2014-09-01) -
Empirical anidulafungin therapy increases the treatment efficacy in invasive candidiasis: ERA study results (EraxisR in the Russian Federation)
by: N. N. Klimko
Published: (2019-10-01) -
Comparing the results of invasive candidiasis prevention with anidulafungin vs. the lipid formulation of amphotericin B in high-risk patients in the early postoperative period after liver transplantation
by: S. V. Zhuravel, et al.
Published: (2020-06-01) -
SUCCESSFUL APPLICATION OF CASPOFUNGIN TO AN INFANT WITH A MAJOR BURNING INJURY COMPLICATED BY INTRUSIVE CANDIDOSIS
by: A.S. Kolbin, et al.
Published: (2008-11-01)